“…have shown that this product actually occurs in small concentrations by in vitro irradiation of sulfanilamide (24). Our 2 retested sulfanilamide cases reacted negatively to PHABSA; however, Burckhardt et al demonstrated that humans photoallergic to the oral antidiabetic, N1-Sulfanilyl-N2-n-butyl-carbamid (Nadisan), a sulfonamide pro duct, reacted to PHABSA as well (6). Other possible oxidation pro ducts mentioned by T horpe and Williams (2-Oxy-benzoxazol-6-sulfonamide, and l-Amino-3-hydroxy-benzene-4 -sulfonamide), were tested for their sensitizing ability; however, they did not demonstrate eczematogenic properties upon guinea-pigs (29,30).…”